Anti-AKT1 + AKT2 + AKT3 antibody [EPR17671]
- RabMAb
- Recombinant
- 20ul selling size
- What is this?
Be the first to review this product! Submit a review
|
(20 Publications)
Rabbit Recombinant Monoclonal AKT1 antibody. Suitable for IP, WB, Flow Cyt (Intra), IHC-P and reacts with Human, Mouse, Rat, Recombinant full length protein - Human samples. Cited in 20 publications.
View Alternative Names
PKB, RAC, AKT1, RAC-alpha serine/threonine-protein kinase, Protein kinase B, Protein kinase B alpha, Proto-oncogene c-Akt, RAC-PK-alpha, PKB alpha, PKBG, AKT3, RAC-gamma serine/threonine-protein kinase, Protein kinase Akt-3, Protein kinase B gamma, RAC-PK-gamma, STK-2, PKB gamma, RAC-beta serine/threonine-protein kinase, Protein kinase Akt-2, Protein kinase B beta, RAC protein kinase beta, PKB beta, RAC-PK-beta, AKT2
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17671] (AB185633)
Intracellular flow cytometric analysis of 2% paraformaldehyde-fixedA549 (Human lung carcinoma) cells labeling AKT1 + AKT2 + AKT3 with ab185633 at 1/50 dilution (red) compared with a rabbit monoclonal IgG isotype control (black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody; blue). Goat anti rabbit IgG (FITC) at 1/150 dilution was used as the secondary antibody.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17671] (AB185633)
Immunohistochemical analysis of paraffin-embedded Human cerebral cortex tissue labeling AKT1 + AKT2 + AKT3 with ab185633 at 1/400 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) secondary antibody at 1/500 dilution. Nuclear and weak cytoplasmic staining on neurons of the Human cerebral cortex is observed. Counter stained with Hematoxylin.
Negative control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17671] (AB185633)
Immunohistochemical analysis of paraffin-embedded Human adenocarcinoma of colon tissue labeling AKT1 + AKT2 + AKT3 with ab185633 at 1/400 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) secondary antibody at 1/500 dilution. Nuclear and weak cytoplasmic staining on Human adenocarcinoma of colon is observed. Counter stained with Hematoxylin.
Negative control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IP
Supplier Data
Immunoprecipitation - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17671] (AB185633)
AKT1 + AKT2 + AKT3 was immunoprecipitated from 1mg of A549 (Human lung carcinoma) whole cell extract with ab185633 at 1/50 dilution. Western blot was performed from the immunoprecipitate using ab185633 at 1/1000 dilution. Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG, was used as secondary antibody at 1/1500 dilution.
Lane 1 : A549 whole cell extract 10 μg (Input). Lane 2 : ab185633 IP in A549 whole cell extract. Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab185633 in A549 whole cell extract.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17671] (ab185633)
Predicted band size: 56 kDa
false
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17671] (AB185633)
Immunohistochemical analysis of paraffin-embedded Mouse cerebral cortex tissue labeling AKT1 + AKT2 + AKT3 with ab185633 at 1/400 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) secondary antibody at 1/500 dilution. Nuclear and weak cytoplasmic staining on neurons of the mouse cerebral cortex is observed. Counter stained with Hematoxylin.
Negative control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17671] (AB185633)
Immunohistochemical analysis of paraffin-embedded Rat kidney tissue labeling AKT1 + AKT2 + AKT3 with ab185633 at 1/400 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) secondary antibody at 1/500 dilution. Nuclear and weak cytoplasmic staining on rat kidney is observed. Counter stained with Hematoxylin.
Negative control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- WB
Supplier Data
Western blot - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17671] (AB185633)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17671] (ab185633) at 1/2000 dilution
Lane 1:
Human fetal brain lysates at 10 µg
Lane 2:
Human fetal kidney lysates at 10 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution
Predicted band size: 56 kDa
Observed band size: 56 kDa
false
- WB
Supplier Data
Western blot - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17671] (AB185633)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17671] (ab185633) at 1/2000 dilution
All lanes:
A549 (Human lung carcinoma) whole cell lysates at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L),Peroxidase conjugated at 1/1000 dilution
Predicted band size: 141 kDa,56 kDa
Observed band size: 141 kDa,56 kDa
false
- WB
Supplier Data
Western blot - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17671] (AB185633)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17671] (ab185633) at 1/2000 dilution
Lane 1:
Mouse brain lysates at 10 µg
Lane 2:
Rat brain lysates at 10 µg
Lane 3:
Rat heart lysates at 10 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution
Predicted band size: 56 kDa
Observed band size: 56 kDa
false
- WB
Supplier Data
Western blot - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17671] (AB185633)
Blocking/Dilution buffer : 5% NFDM/TBST.
The bottom panel is probed with an anti-His tag antibody.
All lanes:
Western blot - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17671] (ab185633) at 1/5000 dilution
Lane 1:
AKT3 recombinant protein fragment (His-Tag®): aa351-479 at 0.01 µg
Lane 2:
AKT2 recombinant protein fragment (His-Tag®): aa282-481 at 0.01 µg
Lane 3:
AKT1 recombinant protein fragment (His-Tag®): aa281-480 at 0.01 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution
Predicted band size: 56 kDa
false
Related conjugates and formulations (3)
-
Anti-AKT1 + AKT2 + AKT3 antibody [EPR17671] - BSA and Azide free
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-AKT1 + AKT2 + AKT3 antibody [EPR17671]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-AKT1 + AKT2 + AKT3 antibody [EPR17671]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
AKT proteins regulate cell cycle growing cell survival proliferation and metabolism. They participate as core components of the PI3K/AKT/mTOR signaling pathway forming complexes with other proteins to transmit signals. They bind to phosphoinositide lipids on the cell membrane facilitating their activation and downstream signaling. Through these activities the AKT transporter proteins maintain cellular homeostasis and play a part in stress response.
Pathways
AKT proteins engage in important signaling networks including the PI3K/AKT pathway and mTOR pathway. They work closely with PI3K and mTOR proteins coordinating cellular growth and energy metabolism. In particular the AKT pathway responds to growth factors and insulin influencing glucose uptake and glycolysis regulation through interaction with proteins such as glycogen synthase kinase 3 (GSK3).
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (20)
Recent publications for all applications. Explore the full list and refine your search
Biology 14: PubMed40427716
2025
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 30: PubMed39370807
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of Cancer 15:5415-5424 PubMed39247610
2024
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 30: PubMed39219289
2024
Applications
Unspecified application
Species
Unspecified reactive species
World journal of gastrointestinal oncology 16:3241-3255 PubMed39072172
2024
Applications
Unspecified application
Species
Unspecified reactive species
Phytotherapy research : PTR 37:195-210 PubMed36097321
2022
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 23:414 PubMed35601067
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 12:791269 PubMed35342388
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of inflammation research 14:4707-4721 PubMed34557015
2021
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 21:1 PubMed33235610
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com